The legislation, which also applies to tobacco and nicotine products, will go into effect on July 1, 2025, the same date that was suggested for the exclusion in last year’s Mid-Year Economic and Fiscal Outlook (MYEFO) papers.
Growing concerns about public subsidies supporting companies linked to addiction and long-term health problems are addressed by the idea.
Taxpayer-funded incentives, according to officials, shouldn’t encourage innovation that can worsen these negative effects.
The exclusions are purposefully broad, encompassing R&D related to gaming machine technologies, wagering platforms, online and offline gambling, and any tobacco or nicotine products, including new alternatives.
According to government documents that go with the draft legislation, funding developments in these fields is incompatible with national health goals and could jeopardize attempts to lower the prevalence of addiction.
Research aimed at preventing problem gambling or reducing the negative health effects of tobacco use will continue to be supported thanks to a tailored exception for studies carried out exclusively for harm-minimization.
The draft measures carry out pledges made in the Mid-Year Economic and Fiscal Outlook 2024–2025, which pointed out that tobacco-adjacent innovation naturally increases exposure to items associated to chronic disease and emphasized the possibility that gambling-related R&D could exacerbate addictive behaviors.
Government debt out of control.
The government’s budgetary constraints were also mentioned in the report. The national debt is expected to reach A$1 trillion by the 2025–2026 fiscal year, and structural deficits are expected to grow.
This provides a practical justification for strengthening incentive schemes and directing public spending toward sectors that are in line with more general health and economic concerns.
Reform was further spurred by fresh data from the Australian Tax Office.
Policymakers said that the almost A$90 million in R&D tax credits that gambling companies sought during the 2021–2022 fiscal year was out of line with the program’s objectives.
Allowing such claims, according to officials, may flood the system with initiatives that provide little public benefit while taking funds away from areas that are thought to be national priorities, such advanced manufacturing, sustainable energy, and medical research.
The impact of the proposed exclusions on investment pipelines and compliance duties is currently being evaluated by relevant and affected businesses in the gambling, health, and research sectors.
Before the final measure is presented to parliament, industrial associations, public health organizations, and research institutes have until January 30, 2026, to provide their opinions on the draft legislation.
It is anticipated that the comment period will assist clarify technical boundaries within the exclusions and guarantee that harm-minimization research is distinct from commercial development.
